Allena Pharma 
Welcome,         Profile    Billing    Logout  
 2 Products   0 Diseases  2 Products   3 Trials   59 News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
reloxaliase (ALLN-177) / Allena Pharma
2017-003547-38: Pilot Study of ALLN-177 in Adult and Pediatric (Child) Subjects Aged 12 Years or Older with Enteric (relates to the intestines) or Primary Hyperoxaluria (oxalate in the urine) and Hyperoxalemia (oxalate in the blood)

Not yet recruiting
2
20
Europe, RoW
ALLN-177, Capsule
Allena Pharmaceuticals, Inc., Allena Pharmaceuticals, Inc.
Enteric or primary hyperoxaluria and hyperoxalemia, Enteric or primary hyperoxaluria and hyperoxalemia, meaning that there is a large amount of oxalate in urine (hyperoxaluria) and blood (hyperoxalemia)., Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
engineered urate oxidase (ALLN-346) / Allena Pharma
NCT04987294: Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Terminated
2a
19
US
ALLN-346, Engineered urate oxidase, Placebo, Matching placebo capsule
Allena Pharmaceuticals
Hyperuricemia, Gout, Chronic Kidney Diseases
09/22
09/22
NCT04987242: An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201)

Completed
2
16
US
ALLN-346, Engineered urate oxidase, Placebo, Matching placebo capsule
Allena Pharmaceuticals
Hyperuricemia, Gout, Chronic Kidney Diseases
03/22
03/22
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
reloxaliase (ALLN-177) / Allena Pharma
2017-003547-38: Pilot Study of ALLN-177 in Adult and Pediatric (Child) Subjects Aged 12 Years or Older with Enteric (relates to the intestines) or Primary Hyperoxaluria (oxalate in the urine) and Hyperoxalemia (oxalate in the blood)

Not yet recruiting
2
20
Europe, RoW
ALLN-177, Capsule
Allena Pharmaceuticals, Inc., Allena Pharmaceuticals, Inc.
Enteric or primary hyperoxaluria and hyperoxalemia, Enteric or primary hyperoxaluria and hyperoxalemia, meaning that there is a large amount of oxalate in urine (hyperoxaluria) and blood (hyperoxalemia)., Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
engineered urate oxidase (ALLN-346) / Allena Pharma
NCT04987294: Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

Terminated
2a
19
US
ALLN-346, Engineered urate oxidase, Placebo, Matching placebo capsule
Allena Pharmaceuticals
Hyperuricemia, Gout, Chronic Kidney Diseases
09/22
09/22
NCT04987242: An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201)

Completed
2
16
US
ALLN-346, Engineered urate oxidase, Placebo, Matching placebo capsule
Allena Pharmaceuticals
Hyperuricemia, Gout, Chronic Kidney Diseases
03/22
03/22

Download Options